Literature DB >> 33812051

Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease.

Brittani R Price1, Lance A Johnson2, Christopher M Norris3.   

Abstract

Astrocyte reactivity is a hallmark of neuroinflammation that arises with Alzheimer's disease (AD) and nearly every other neurodegenerative condition. While astrocytes certainly contribute to classic inflammatory processes (e.g. cytokine release, waste clearance, and tissue repair), newly emerging technologies for measuring and targeting cell specific activities in the brain have uncovered essential roles for astrocytes in synapse function, brain metabolism, neurovascular coupling, and sleep/wake patterns. In this review, we use a holistic approach to incorporate, and expand upon, classic neuroinflammatory concepts to consider how astrocyte dysfunction/reactivity modulates multiple pathological and clinical hallmarks of AD. Our ever-evolving understanding of astrocyte signaling in neurodegeneration is not only revealing new drug targets and treatments for dementia but is suggesting we reimagine AD pathophysiological mechanisms.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Alzheimer’s disease; Astrocytes; Dementia; Neurodegeneration; Neuroinflammation; Reactive astrocytes

Year:  2021        PMID: 33812051     DOI: 10.1016/j.arr.2021.101335

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  13 in total

Review 1.  Astrocytes in Neurodegeneration: Inspiration From Genetics.

Authors:  Jingxuan Huang; Chunyu Li; Huifang Shang
Journal:  Front Neurosci       Date:  2022-06-24       Impact factor: 5.152

Review 2.  TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications.

Authors:  Jian Luo
Journal:  Biomedicines       Date:  2022-05-23

Review 3.  Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease.

Authors:  Xian Zhou; Madhuri Venigalla; Ritesh Raju; Gerald Münch
Journal:  J Neural Transm (Vienna)       Date:  2022-03-16       Impact factor: 3.850

Review 4.  Emerging roles of N-linked glycosylation in brain physiology and disorders.

Authors:  Lindsey R Conroy; Tara R Hawkinson; Lyndsay E A Young; Matthew S Gentry; Ramon C Sun
Journal:  Trends Endocrinol Metab       Date:  2021-10-29       Impact factor: 10.586

Review 5.  Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome.

Authors:  Alessandra C Martini; Thomas J Gross; Elizabeth Head; Mark Mapstone
Journal:  Neuron       Date:  2022-04-25       Impact factor: 18.688

Review 6.  Biofluid Biomarkers of Alzheimer's Disease: Progress, Problems, and Perspectives.

Authors:  Shan Huang; Yan-Jiang Wang; Junhong Guo
Journal:  Neurosci Bull       Date:  2022-03-19       Impact factor: 5.271

Review 7.  Effects of gut microbiota and probiotics on Alzheimer's disease.

Authors:  Libing Guo; Jiaxin Xu; Yunhua Du; Weibo Wu; Wenjing Nie; Dongliang Zhang; Yuling Luo; Huixian Lu; Ming Lei; Songhua Xiao; Jun Liu
Journal:  Transl Neurosci       Date:  2021-12-27       Impact factor: 1.757

Review 8.  The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer's Disease.

Authors:  Gilbert Ogunmokun; Saikat Dewanjee; Pratik Chakraborty; Chandrasekhar Valupadas; Anupama Chaudhary; Viswakalyan Kolli; Uttpal Anand; Jayalakshmi Vallamkondu; Parul Goel; Hari Prasad Reddy Paluru; Kiran Dip Gill; P Hemachandra Reddy; Vincenzo De Feo; Ramesh Kandimalla
Journal:  Cells       Date:  2021-10-18       Impact factor: 6.600

9.  The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5×FAD transgenic mice.

Authors:  Zhiman Liang; Xin Li; Xiaoting Luo; Hongjie Luo; Yajun Chen; Mingliang Cai; Xinxin Zhong; Yingying Fang; Ting Guo; Yusheng Shi; Xingmei Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-28       Impact factor: 8.886

Review 10.  PET imaging of reactive astrocytes in neurological disorders.

Authors:  Yu Liu; Han Jiang; Xiyi Qin; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-07       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.